April 7, 2005: Pfizer Voluntarily Withdraws Bextra

On April 7th, 2005, the Food and Drug Administration (FDA) announced that it has asked Pfizer, Inc. to voluntarily withdraw Bextra (valdecoxib) from the U.S. market. Pfizer agreed to suspend sales and marketing of Bextra in the U.S., pending further discussions with the FDA.